The clinical information you need, at your fingertips.

New nasal spray product broadens consumer access to life-saving overdose reversal medication. . .

A new test identifies the roughly one in four metastatic hormone-sensitive prostate cancers with PTEN protein loss, an aggressive subgroup that until now lacked a targeted option. . .

This is the first PD-1 and HIF-2α inhibitor combination to show improved disease-free survival after nephrectomy. . .

Short-term treatment improved memory, attention, and executive function in adults with remitted depression. . .

HLA-DRB1*01:03 was linked to earlier, harder-to-treat disease across Crohn’s disease and ulcerative colitis. . .